Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort

Objective Pancreatic cancer diagnoses are frequently preceded by a new diabetes diagnosis. Screening individuals newly diagnosed with diabetes could enable the earlier detection of pancreatic cancer. We sought to estimate the risk of pancreatic cancer by age, sex, race and time since diabetes diagno...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Goggins, Bryan Lau, Elham Afghani, Laura K Becker, Alison P Klein
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e099488.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849718750394187776
author Michael Goggins
Bryan Lau
Elham Afghani
Laura K Becker
Alison P Klein
author_facet Michael Goggins
Bryan Lau
Elham Afghani
Laura K Becker
Alison P Klein
author_sort Michael Goggins
collection DOAJ
description Objective Pancreatic cancer diagnoses are frequently preceded by a new diabetes diagnosis. Screening individuals newly diagnosed with diabetes could enable the earlier detection of pancreatic cancer. We sought to estimate the risk of pancreatic cancer by age, sex, race and time since diabetes diagnosis.Design Claims-based cohort study.Setting Johns Hopkins Medicine conducted this deidentified claims-based cohort study using the Optum Labs Data Warehouse.Participants Insurance enrollees from 1/2008–9/2018 were identified as non-diabetic or newly diagnosed diabetic. Our risk set included 4 732 313 individuals (424 129 newly diabetic) in 5 844 934 enrolment periods.Primary outcome measures Time to pancreatic cancer. Diabetes and cancer were defined using International Classification of Diseases (ICD)-9/10 codes.Results Individuals with newly diagnosed diabetes were at an increased HR of pancreatic cancer, but this effect waned over time. The HR of pancreatic cancer following a diabetes diagnosis was higher in younger individuals and varied by race (lower HR in non-White individuals) (p<0.01, main effects and interactions). Thus, the probability of pancreatic cancer following a diabetes diagnosis was dependent on age, race and sex. For example, the 1-year probability of pancreatic cancer in a White male aged 75 was 0.45% (95%CI 0.41% to 0.49%) if they were newly diagnosed with diabetes and 0.090% (95%CI 0.084% to 0.096%) if they were free of diabetes. In contrast, the risk was lower at 0.15% (new-diabetic, 95% CI 0.13% to 0.16%) and 0.022% (diabetes free, 95%CI 0.020% to 0.023%) at age 55. The HR of pancreatic cancer for individuals with newly diagnosed diabetes compared with those free of diabetes was highest in the month following diagnosis (HR=14.7 and 9.6 for a 55 and 75 year old White male, respectively) but decreased in the following months, with a HR of 7.8 and 5.8 at 3 months, 5.6 and 4.1 at 6 months, and 3.9 and 2.8 at 1 year (p<0.01).Conclusions Consideration of the age–race–sex specific probability of pancreatic cancer and time since diabetes diagnosis is necessary when evaluating the risk of pancreatic cancer following a diabetes diagnosis.
format Article
id doaj-art-8fdc8d354a7e40f3bf4992505fcc401e
institution DOAJ
issn 2044-6055
language English
publishDate 2025-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-8fdc8d354a7e40f3bf4992505fcc401e2025-08-20T03:12:19ZengBMJ Publishing GroupBMJ Open2044-60552025-05-0115510.1136/bmjopen-2025-099488Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohortMichael Goggins0Bryan Lau1Elham Afghani2Laura K Becker3Alison P Klein4Division of Gastroenterology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD, USADepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USADivision of Gastroenterology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD, USAOptumLabs, Eden Prairie, Minnesota, USADivision of Gastroenterology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD, USAObjective Pancreatic cancer diagnoses are frequently preceded by a new diabetes diagnosis. Screening individuals newly diagnosed with diabetes could enable the earlier detection of pancreatic cancer. We sought to estimate the risk of pancreatic cancer by age, sex, race and time since diabetes diagnosis.Design Claims-based cohort study.Setting Johns Hopkins Medicine conducted this deidentified claims-based cohort study using the Optum Labs Data Warehouse.Participants Insurance enrollees from 1/2008–9/2018 were identified as non-diabetic or newly diagnosed diabetic. Our risk set included 4 732 313 individuals (424 129 newly diabetic) in 5 844 934 enrolment periods.Primary outcome measures Time to pancreatic cancer. Diabetes and cancer were defined using International Classification of Diseases (ICD)-9/10 codes.Results Individuals with newly diagnosed diabetes were at an increased HR of pancreatic cancer, but this effect waned over time. The HR of pancreatic cancer following a diabetes diagnosis was higher in younger individuals and varied by race (lower HR in non-White individuals) (p<0.01, main effects and interactions). Thus, the probability of pancreatic cancer following a diabetes diagnosis was dependent on age, race and sex. For example, the 1-year probability of pancreatic cancer in a White male aged 75 was 0.45% (95%CI 0.41% to 0.49%) if they were newly diagnosed with diabetes and 0.090% (95%CI 0.084% to 0.096%) if they were free of diabetes. In contrast, the risk was lower at 0.15% (new-diabetic, 95% CI 0.13% to 0.16%) and 0.022% (diabetes free, 95%CI 0.020% to 0.023%) at age 55. The HR of pancreatic cancer for individuals with newly diagnosed diabetes compared with those free of diabetes was highest in the month following diagnosis (HR=14.7 and 9.6 for a 55 and 75 year old White male, respectively) but decreased in the following months, with a HR of 7.8 and 5.8 at 3 months, 5.6 and 4.1 at 6 months, and 3.9 and 2.8 at 1 year (p<0.01).Conclusions Consideration of the age–race–sex specific probability of pancreatic cancer and time since diabetes diagnosis is necessary when evaluating the risk of pancreatic cancer following a diabetes diagnosis.https://bmjopen.bmj.com/content/15/5/e099488.full
spellingShingle Michael Goggins
Bryan Lau
Elham Afghani
Laura K Becker
Alison P Klein
Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort
BMJ Open
title Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort
title_full Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort
title_fullStr Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort
title_full_unstemmed Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort
title_short Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims-based cohort
title_sort impact of race sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetes in a claims based cohort
url https://bmjopen.bmj.com/content/15/5/e099488.full
work_keys_str_mv AT michaelgoggins impactofracesexandageontheprobabilityofpancreaticcanceramongpatientswithnewlydiagnoseddiabetesinaclaimsbasedcohort
AT bryanlau impactofracesexandageontheprobabilityofpancreaticcanceramongpatientswithnewlydiagnoseddiabetesinaclaimsbasedcohort
AT elhamafghani impactofracesexandageontheprobabilityofpancreaticcanceramongpatientswithnewlydiagnoseddiabetesinaclaimsbasedcohort
AT laurakbecker impactofracesexandageontheprobabilityofpancreaticcanceramongpatientswithnewlydiagnoseddiabetesinaclaimsbasedcohort
AT alisonpklein impactofracesexandageontheprobabilityofpancreaticcanceramongpatientswithnewlydiagnoseddiabetesinaclaimsbasedcohort